Developing a Peer Support Intervention for Depression in SCD

NCT06358404 | Active Not Recruiting DMC

• 1 other identifier: 2024P000615
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to assess the feasibility, acceptability, and fidelity of an 8-week intervention where peer coaches will deliver depression care to adults 60 years of age or older who have depression and subjective cognitive decline.

Conditions

Subjective Cognitive Decline; Depression in Old Age

Outcome Measures

Primary Outcomes (3)

• Feasibility of Intervention

  Level of participant engagement: how many screened older adults agree to participate in the intervention and complete baseline assessments

  Measured at baseline enrollment

• Acceptability of Intervention

  Number of meetings older adults complete with peer coach

  Measured during intervention (8 weeks)

• Fidelity of Intervention

  Degree of adherence to intervention

  Measured during intervention (8 weeks)

Study Arms (1)

Intervention

OTHER

Peer coaches will deliver the PeersCOG intervention to participants.

Behavioral: PeersCOG

Interventions

PeersCOG BEHAVIORAL

. The intervention will consist of 8 weekly video chats focused on emotional, appraisal, and informational support delivered by community-based older adult peer coaches to adults 60 years of age and older with subthreshold depression and SCD.

Intervention

Eligibility Criteria

• Age: 60 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Older adults aged 60+
• Endorse subjective cognitive decline
• Endorse depressive symptoms
• not currently experiencing suicidal ideation nor active, untreated manic, psychotic, or substance use disorder
• fluent in English and able to give informed consent

You may not qualify if:

• Meets diagnostic criteria for mild cognitive impairment or Alzheimer's dementia
• Meets diagnostic criteria for a current major depressive disorder
• have a history of neurological and psychiatric comorbidities such as major depressive disorder in the past 12 months

Sponsors & Collaborators

• Massachusetts General Hospital: lead
• National Institutes of Health (NIH): collaborator

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: April 5, 2024
• First Posted: April 10, 2024
• Study Start: May 1, 2024
• Primary Completion (Estimated): May 31, 2027
• Study Completion (Estimated): May 31, 2027
• Last Updated: July 13, 2026

Record last verified: 2026-07

Locations

US (1)